Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
2000 2
2004 2
2006 1
2007 1
2009 5
2010 10
2011 9
2012 17
2013 22
2014 30
2015 22
2016 24
2017 17
2018 9
2019 17
2020 21
2021 18
2022 13
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

217 results
Results by year
Filters applied: . Clear all
Page 1
Targeting the bone marrow microenvironment in multiple myeloma.
Kawano Y, Moschetta M, Manier S, Glavey S, Görgün GT, Roccaro AM, Anderson KC, Ghobrial IM. Kawano Y, et al. Among authors: moschetta m. Immunol Rev. 2015 Jan;263(1):160-72. doi: 10.1111/imr.12233. Immunol Rev. 2015. PMID: 25510276 Review.
Progression signature underlies clonal evolution and dissemination of multiple myeloma.
Shen YJ, Mishima Y, Shi J, Sklavenitis-Pistofidis R, Redd RA, Moschetta M, Manier S, Roccaro AM, Sacco A, Tai YT, Mercier F, Kawano Y, Su NK, Berrios B, Doench JG, Root DE, Michor F, Scadden DT, Ghobrial IM. Shen YJ, et al. Among authors: moschetta m. Blood. 2021 Apr 29;137(17):2360-2372. doi: 10.1182/blood.2020005885. Blood. 2021. PMID: 33150374 Free PMC article.
Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer.
Smyth LM, Tamura K, Oliveira M, Ciruelos EM, Mayer IA, Sablin MP, Biganzoli L, Ambrose HJ, Ashton J, Barnicle A, Cashell DD, Corcoran C, de Bruin EC, Foxley A, Hauser J, Lindemann JPO, Maudsley R, McEwen R, Moschetta M, Pass M, Rowlands V, Schiavon G, Banerji U, Scaltriti M, Taylor BS, Chandarlapaty S, Baselga J, Hyman DM. Smyth LM, et al. Among authors: moschetta m. Clin Cancer Res. 2020 Aug 1;26(15):3947-3957. doi: 10.1158/1078-0432.CCR-19-3953. Epub 2020 Apr 20. Clin Cancer Res. 2020. PMID: 32312891 Free PMC article. Clinical Trial.
Macrophages in multiple myeloma.
Ribatti D, Moschetta M, Vacca A. Ribatti D, et al. Among authors: moschetta m. Immunol Lett. 2014 Oct;161(2):241-4. doi: 10.1016/j.imlet.2013.12.010. Epub 2013 Dec 24. Immunol Lett. 2014. PMID: 24370642 Review.
Unraveling the Wide Spectrum of Melanoma Biomarkers.
Revythis A, Shah S, Kutka M, Moschetta M, Ozturk MA, Pappas-Gogos G, Ioannidou E, Sheriff M, Rassy E, Boussios S. Revythis A, et al. Among authors: moschetta m. Diagnostics (Basel). 2021 Jul 26;11(8):1341. doi: 10.3390/diagnostics11081341. Diagnostics (Basel). 2021. PMID: 34441278 Free PMC article. Review.
Targeting the Bone Marrow Microenvironment.
Moschetta M, Kawano Y, Podar K. Moschetta M, et al. Cancer Treat Res. 2016;169:63-102. doi: 10.1007/978-3-319-40320-5_6. Cancer Treat Res. 2016. PMID: 27696259 Review.
Resonant Enhancement of Polymer-Cell Optostimulation by a Plasmonic Metasurface.
Maity A, Perotto S, Moschetta M, Hua H, Sardar S, Paternò GM, Tian J, Klein M, Adamo G, Lanzani G, Soci C. Maity A, et al. Among authors: moschetta m. ACS Omega. 2022 Nov 16;7(47):42674-42680. doi: 10.1021/acsomega.2c04812. eCollection 2022 Nov 29. ACS Omega. 2022. PMID: 36467911 Free PMC article. Review.
217 results